1305-0013 Trial Investigators 2022, ' Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis ', New England Journal of Medicine, vol. 386, no. 23, pp. 2178-2187 . https://doi.org/10.1056/NEJMoa2201737 New England Journal of Medicine, 386(23), 2178-2187. Massachussetts Medical Society
Expert Review of Respiratory Medicine r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau instname
Kalluri, M, Luppi, F, Vancheri, A, Vancheri, C, Balestro, E, Varone, F, Mogulkoc, N, Cacopardo, G, Bargagli, E, Renzoni, E, Torrisi, S, Calvello, M, Libra, A, Pavone, M, Bonella, F, Cottin, V, Valenzuela, C, Wijsenbeek, M & Bendstrup, E 2021, ' Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease : Where to go from here? ', European Respiratory Review, vol. 30, no. 160, 210026 . https://doi.org/10.1183/16000617.0026-2021